Michal Tsur
Israeli entrepreneur
Michal Tsur (Hebrew: מיכל צור; born 1973) is an Israeli serial entrepreneur who lived in New York.2
From Wikipedia’s article on Michal Tsur (this version), CC BY-SA 4.0.
Born 1973.1
About
She is the co-founder and co-CEO of Remepy, and was co-founder and president of Kaltura, Nasdaq: KLTR, and co-founder and vice-president of Cyota, acquired by RSA Security Nasdaq: RSAS.
From Wikipedia’s article on Michal Tsur, shared under CC BY-SA 4.0.2
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
Early life and education
- Date not recordedHebrew University of Jerusalem3
- Date not recordedNew York University3
- Date not recordedHebrew University Secondary School3
Tsur was born in Jerusalem. She completed a doctoral degree in Law, focusing on game theoretic economic analysis of law from New York University. She was then a post-doctoral fellow at Yale Law School's Information Society Project.
From Wikipedia’s article on Michal Tsur (this version), CC BY-SA 4.0.
Career
Occupation: chief executive officer.6
Tsur launched her career in the law sector as a clerk at the Supreme Court of Israel. She was driven by research, working at Hebrew University in Jerusalem and the Israeli Democracy Institute.
In 1999, Tsur co-founded Cyota, a cybersecurity company, together with Ben Enosh, Lior Golan and Naftali Bennett. Cyota was acquired by RSA Security in 2005.
After Cyota was acquired, Tsur and a few friends co-founded Kaltura, an open source video platform, in 2006.
Kaltura was listed on Nasdaq:KLTR in 2021.
in 2022, Tsur together with 2 friends, co-founded Remepy, to bring to market Hybrid Drugs, that combine tranditional drugs with therapeutic software.
in 2024 it was announced that former Prime-minister of Israel Naftali Bennett, who was Tsur's partner at Cyota will be joining her on Remepy's board of directors.
Later on that year Tsur was quoted that the best Parkinson'd Disease medication will be developed in Israel and it will be hybrid.
Tsur has authored and contributed to many articles regarding women in tech.
From Wikipedia’s article on Michal Tsur (this version), CC BY-SA 4.0.
Personal life
Links
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataMichal Tsur on Wikidata
- 2WikipediaMichal Tsur on Wikipedia
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11WikidataMichal Tsur: X, on Wikidata
- 12
- 13WikidataCyota, Founder
- 14WikidataKaltura, Founder
- 15SEC EDGARKaltura, Officer
- 16
- 17SEC EDGARForm 4 filed Jul 21, 2022
- 18SEC EDGARForm 4 filed Mar 17, 2022
- 19SEC EDGARForm 4 filed Dec 10, 2021
- 20Wikimedia CommonsMichal Tsur photo by Lishkee, CC BY-SA 4.0